).
4.2: We suggest one-time screening CTA (or MRA) of the
head, neck, and chest for those patients with segmental
arterial mediolysis. Level of Recommendation: Grade 2
(Weak), Quality of Evidence: C (Low).
5.1: We suggest interval surveillance (ie, every 1224 months) with axial imaging (ie, CTA or MRA) in cases
of segmental medial arteriolysis in